MCY vs MRK · P/E 6.7, rev $3.22B vs P/E 33, rev $16.61B
Mercury General Corporation (MCY) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Mercury General Corporation (MCY) is a insurance - property & casualty company listed on NYSE.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported MCY revenue for 2026-06-30 was $3.22B. Net income was $453.9M. MCY currently screens at market cap $5.62B and trailing P/E 6.7.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
MCY currently screens at market cap $5.62B and trailing P/E 6.7. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the MCY and MRK stock pages for the full models.
Not investment advice.